腘动脉慢性完全闭塞伴或不伴远端着陆区的血管成形术对比
本研究回顾性分析80例因腘动脉慢性完全闭塞行经皮腔内血管成形术的重症肢体缺血患者,比较有远端着陆区(DLZ)与无DLZ病变的结局。糖尿病是无DLZ病变的独立危险因素。12个月时两组保肢率、一期通畅率和总生存率无显著差异,但DLZ组免于靶病变血运重建和免于主要肢体不良事件显著更优。
要点
- 糖尿病是无DLZ病变的危险因素(HR 2.58)。
- DLZ组12个月免于TLR和免于MALE显著更优。
- 两组保肢率、一期通畅率和生存率无显著差异。
核心结论
- 糖尿病是无DLZ病变的显著危险因素(HR 2.58;95%CI 1.03-6.46;P=0.04)。
- DLZ病变12个月免于TLR(92.1% vs. 67.7%;P=0.03)和免于MALE(80.1% vs. 41.8%;P=0.003)显著高于无DLZ病变。
- 两组12个月保肢率、一期通畅率和总生存率无显著差异。
研究设计与样本
- 回顾性分析80例因腘动脉慢性完全闭塞行经皮腔内血管成形术(伴或不伴支架)的重症肢体缺血患者(Rutherford 5-6级),均无流入道病变。
- 按是否存在远端着陆区(DLZ)分为DLZ组(40例,50%)和无DLZ组(40例,50%)。
主要发现
- 全组43例男性,平均年龄70.2岁;DLZ组糖尿病显著更常见。
- DLZ组与无DLZ组支架置入率分别为45.0%和42.5%(P=1.0)。
- 12个月一期通畅率64.7% vs. 51.6%(P=0.156),总生存率73.4% vs. 84.0%(P=0.283),免于截肢生存率60.0% vs. 68.8%(P=0.432),保肢率93.6% vs. 82.2%(P=0.126)。
- 12个月免于TLR 92.1% vs. 67.7%(P=0.03),免于MALE 80.1% vs. 41.8%(P=0.003),DLZ组均显著更高。
临床怎么用
- 对于腘动脉慢性完全闭塞的重症肢体缺血患者,存在DLZ时行血管成形术可显著降低12个月靶病变血运重建和主要肢体不良事件风险。
- 糖尿病是无DLZ病变的危险因素,对糖尿病患者应关注DLZ状态以优化治疗策略。
局限性
- 本研究为回顾性分析,样本量80例,可能存在选择偏倚。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this study was to evaluate the outcome of percutaneous transluminal angioplasty in patients with critical limb ischemia due to popliteal artery (PA) chronic total occlusions depending on the presence of a patent portion of the PA distal to the occlusive lesion-the distal landing zone (DLZ). MATERIALS AND METHODS: We retrospectively analyzed 80 patients with critical limb ischemia (all Rutherford class 5-6), who underwent percutaneous transluminal angioplasty with or without stenting for PA chronic total occlusions with no inflow disease. Baseline demographic and clinical variables, periprocedural outcome, 12-month overall survival, limb salvage, primary patency, freedom from target lesion revascularization (TLR), amputation-free survival, and freedom from major adverse limb events in DLZ versus no-DLZ lesions were assessed. RESULTS: Of all patients (43 men; mean age 70.2 y), 40 (50%) had DLZ in the PA, whereas another 40 (50%) did not (no-DLZ). Diabetes was significantly more common among DLZ patients and was found to be a risk factor for DLZ compared with no-DLZ lesions (HR 2.58; 95% CI 1.03-6.46; P = 0.04). Other demographic and clinical variables were similar between the groups. The stenting rate was 45.0% versus 42.5% in DLZ versus no-DLZ (P = 1.0). At 12 months, there was no significant difference in primary patency (64.7% vs. 51.6%; P = 0.156), overall survival (73.4% vs. 84.0%; P = 0.283), amputation-free survival (60.0% vs. 68.8%; P = 0.432), and limb salvage rate (93.6% vs. 82.2%; P = 0.126) between DLZ and no-DLZ groups, respectively. However, freedom from TLR (92.1% vs. 67.7%; P = 0.03) and major adverse limb events (80.1% vs. 41.8%; P = 0.003) was significantly higher in DLZ compared with no-DLZ lesions (92.1% vs. 67.7%; P = 0.03). CONCLUSIONS: Diabetes was found to be a significant risk factor for DLZ compared to no-DLZ lesions. Technical success and stenting rates were similar in DLZ versus no-DLZ patients. At 12 months, there was no significant difference in limb salvage, primary patency, and overall survival between the study groups. The DLZ lesions were associated with a significantly higher freedom from TLR than no-DLZ lesions.
引用
- Kurianov P, Lipin A, Antropov A, et al. Popliteal Artery Angioplasty for Chronic Total Occlusions with versus without the Distal Landing Zone. Ann Vasc Surg. 2020. PMID: 32428645. doi:10.1016/j.avsg.2020.04.054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。